Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is essentially a “GP of IP” – a true full-service IP firm with experts in every area of intellectual property and every technology. A comprehensive approach to clients’ needs and Finnegan’s mega-boutique size underpin their year-to-year, decade-to-decade preeminence in intellectual property across all industries and tribunals. From offices in the United States, Asia and Europe, Finnegan continues to be one of the world’s largest firms focusing on intellectual property, practising all aspects of patent, trademark, copyright and trade secret law, representing clients on IP issues relating to US and European patent and trademark law, international trade, portfolio management, the Internet, cybersecurity, e-commerce, government contracts, antitrust andunfair competition.

Finnegan offers full-service IP legal experience and technical expertise in virtually every industry and technology, including biotechnology, pharmaceuticals, biologics and biosimilars, chemicals, electronics, semiconductors, computers and software, automotive, aerospace and aviation, industrial manufacturing, consumer products, medical devices, clean energy and renewables, robotics, sports and fitness, textiles and three-dimensional printing.

With the firm’s practice specialising in intellectual property, it can create economies of scale and focus all resources on providing the best tools, practices and procedures for clients’ IP matters. More than 300 of Finnegan’s legal professionals hold degrees in scientific disciplines (over 65 hold PhDs), over 225 are registered to practise before the US Patent and Trademark Office (USPTO) and more than 30 are former USPTO patent examiners. With more than 50 years’ IP experience, Finnegan handles hundreds of litigations across the spectrum of IP-related venues, including district courts, the US International Trade Commission (ITC), the USPTO’s Patent Trial and Appeal Board (PTAB), the Federal Circuit – where they have briefed and argued more cases than any other law firm – and the US Supreme Court. Since being the first to file a petition and subsequently argue a post-grant review of a covered business method case following the implementation of the America Invents Act, Finnegan is one of the busiest law firms representing petitioners and patent owners in post-grant review proceedings, with more than 90 covered business method reviews, more than 10 post-grant reviews (relatively few of which have been filed at the PTAB) and over 600 inter partes review proceedings. The firm files approximately 2,500 US and 1,000 foreign patent applications annually, and regularly manages large global trademark portfolios, including portfolios totaling more than 10,000 registrations and applications in over 200 countries.

Surveys conducted by legal and business publications consistently rank Finnegan as one of the leading IP law practices in the world. The firm is consistently ranked in the United States for contentious and prosecution trademark and patent work by publications including Managing Intellectual Property and The Legal 500, which has ranked Finnegan as a top-tier firm in nearly every significant IP category since 2009. The publications cite the firm’s winning record, technical expertise and deep bench of talent in all aspects of IP litigation, including trials, appeals and proceedings at the USPTO and ITC investigations.

Representative engagements

  • Represented patent owner Fluidra in appeal involving robotic pool cleaners; successfully petitioned Federal Circuit for en banc review of statutory burden of proof issue; en banc court changed legal standard and vacated invalidity ruling against Fluidra (In re Aqua Products, Inc)
  • Successfully represented Allergan/Forest Laboratories in two Abbreviated New Drug Application litigations, maintaining patent protection for Saphris® (the treatment of schizophrenia and manic and mixed episodes associated with bipolar I disorder) and Savella® (treatment of fibromyalgia)
  • Successfully represented defendant FedEx in district court litigations relating to patents directed to processes used in connection with tracking the location and certain conditions of packages. Filed inter partes re-examination and inter partes review proceedings challenging patents at issue, leading to invalidation of all claims. Affirmed on appeal
  • Provides strategic worldwide IP counselling to Vertex with a focus on US Food and Drug Administration (FDA) approved cystic fibrosis products, including Kalydeco® and Orkambi®, for several still-expanding patent portfolios protecting these and future products for cystic fibrosis
  • Filed a wave of 30 litigations against 26 different sets of defendants seeking FDA approval to market generic versions of Biogen’s blockbuster Tecfidera® product for treating multiple sclerosis
  • Represented a Hangzhou Chic, a Chinese hoverboard manufacturer, in several ITC investigations, securing rulings of non-infringement

Contact details

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
901 New York Avenue North West
Washington DC 20001-4413
United States

Professional contacts

Other offices

  • Atlanta
  • Boston
  • London
  • Palo Alto
  • Reston
  • Seoul
  • Shanghai
  • Taipei
  • Tokyo

Sample client list

  • AstraZeneca
  • Eli Lilly
  • FedEx
  • FIS
  • LG
  • Nestlé
  • Oath
  • Otsuka
  • Philips
  • Sony
  • Toshiba
  • Toyota

Other recommended individuals at this firm